Alnylam Pharmaceuticals Inc (ALNY)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

675 WEST KENDALL STREET CAMBRIDGE, MA 02142

Operates a biopharmaceutical company seeking to develop and commercialize new drugs that work through a recently discovered system in cells known as RNA interference (RNAi). Initial programs are focused on an eye disease (macular degeneration) and lung disease (respiratory syncytial virus).

Data based on most recent fiscal year report
Market Cap13.154 Billion Shares Outstanding111.49 Million Avg Volume1.05 Million
1-Yr BETA vs S&P TR1.393 Current Ratio6.69 Quick Ratio6.56
View SEC Filings from ALNY instead.

View recent insider trading info

Funds Holding ALNY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALNY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SONI MANMEET SINGH CHIEF FINANCIAL OFFICER

  • Officer
0 2020-01-02 1

BONNEY MICHAEL W

  • Director
0 2019-12-31 1

MARAGANORE JOHN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-12-23 7

GREENE BARRY E PRESIDENT

  • Officer
0 2019-12-23 6

VAISHNAW AKSHAY PRESIDENT, R&D

  • Officer
0 2019-12-23 5

KEATING LAURIE EVP, CHIEF LEGAL OFFICER

  • Officer
0 2019-12-23 5

GREENSTREET YVONNE CHIEF OPERATING OFFICER

  • Officer
0 2019-12-23 7

REITAN COLLEEN F

  • Director
11,687 2019-12-05 1

FANUCCI MARSHA

  • Director
0 2019-11-20 2

SHARP PHILLIP A

  • Director
266,899 2019-11-18 3

SATO VICKI L

  • Director
1,669,110 2019-10-10 0

SCHIMMEL PAUL

  • Director
0 2019-10-04 1

SANOFI

23,350,365 2019-09-10 0

POULTON JEFFREY V. CHIEF FINANCIAL OFFICER

  • Officer
0 2019-08-13 1

PAUL STEVEN M PRESIDENT & CEO

  • Officer
  • Director
106,485 2019-07-02 1

AUSIELLO DENNIS A

  • Director
0 2019-07-01 1

SCHULMAN AMY W

  • Director
0 2019-07-01 1

PYOTT DAVID E I

  • Director
0 2019-07-01 1

HAMBURG MARGARET A

  • Director
0 2019-07-01 1

ALLEN PATRICIA L

  • Director
0 2019-06-11 0

STARR KEVIN P

0 2019-06-05 0

CLARKE JOHN K

  • Director
0 2019-05-08 0

MASON MICHAEL SVP, CFO & TREASURER

  • Officer
0 2019-02-25 0

SCHMIDT JOHN A JR

  • Director
0 2017-05-25 0

GROS DAVID-ALEXANDRE C PRESIDENT & COO

  • Officer
0 2017-02-06 0

REID LAURENCE SVP, CHIEF BUSINESS OFFICER

  • Officer
No longer subject to file 2014-12-31 0

NOVARTIS PHARMA AG

NOVARTIS AG

  • 10% Owner
No longer subject to file 2014-08-05 0

DZAU VICTOR J

18,610 2014-06-30 0

KOBLAN KENNETH S CHIEF SCIENTIFIC OFFICER

  • Officer
357 2010-12-08 0

SCOLNICK EDWARD M

  • Director
No longer subject to file 2010-07-14 0

VINCENT JAMES L

  • Director
0 2010-06-17 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GREENSTREET YVONNE - Officer CHIEF OPERATING OFFICER

2019-12-23 A 8,333 a 16,666 0.00 direct

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2019-12-23 A 8,333 a 16,666 0.00 direct

GREENE BARRY E - Officer PRESIDENT

2019-12-23 A 9,999 a 19,998 0.00 direct

KEATING LAURIE - Officer EVP, CHIEF LEGAL OFFICER

2019-12-23 A 4,583 a 9,166 0.00 direct

MARAGANORE JOHN - Director - Officer CHIEF EXECUTIVE OFFICER

2019-12-23 A 17,498 a 34,996 0.00 direct

GREENSTREET YVONNE - Officer CHIEF OPERATING OFFICER

2019-12-12 A 7,500 a 9,416 6,615.00 direct

GREENSTREET YVONNE - Officer CHIEF OPERATING OFFICER

2019-12-12 F 3,208 $120.61 d 6,208 6,615.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments